{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:21:38Z","timestamp":1790169698685,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["5 P30 NS069375 05"],"award-info":[{"award-number":["5 P30 NS069375 05"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neuropharm.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T23:31:25Z","timestamp":1484263885000},"page":"371-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist"],"prefix":"10.1016","volume":"116","author":[{"given":"Pooneh Memar","family":"Ardestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitna","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Coutellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Shamloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.010_bib1","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","article-title":"Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP\/PS1 transgenic mice","volume":"184","author":"Blanchard","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","article-title":"Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease","volume":"1","author":"Bondareff","year":"1987","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","article-title":"Administration of a selective beta2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Branca","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neurobiolaging.2003.10.006","article-title":"Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's","volume":"25","author":"Bullido","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"International union of pharmacology nomenclature of adrenoceptors","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nlm.2015.11.019","article-title":"Analysis of coherent activity between retrosplenial cortex, hippocampus, thalamus, and anterior cingulate cortex during retrieval of recent and remote context fear memory","volume":"127","author":"Corcoran","year":"2016","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acn3.57","article-title":"beta1-adrenergic receptor activation enhances memory in Alzheimer's disease model","volume":"1","author":"Coutellier","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","article-title":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease","volume":"65","author":"Cunningham","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuropharm.2013.09.027","article-title":"Noradrenaline acting on astrocytic beta(2)-adrenoceptors induces neurite outgrowth in primary cortical neurons","volume":"77","author":"Day","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-6606-3-34","article-title":"Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease","volume":"3","author":"Devi","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.neurobiolaging.2011.10.027","article-title":"Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism","volume":"33","author":"Dhawan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/brb3.41","article-title":"Thy1-hAPP(Lond\/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function","volume":"2","author":"Faizi","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","article-title":"Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer","volume":"43","author":"Faizi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib17","first-page":"319","article-title":"Desensitization of G protein-coupled receptors","volume":"51","author":"Freedman","year":"1996","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib18","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(98)00003-2","article-title":"Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor","volume":"242","author":"Fujita","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.22267","article-title":"Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease","volume":"24","author":"Girard","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib22","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.22-07-02434.2002","article-title":"Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease","volume":"22","author":"Heneka","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib23","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib25","doi-asserted-by":"crossref","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.neurobiolaging.2009.09.003","article-title":"Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease","volume":"32","author":"Kaczorowski","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib27","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1471-4159.1989.tb09242.x","article-title":"Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus","volume":"53","author":"Kalaria","year":"1989","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","article-title":"Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease","volume":"28","author":"Kalinin","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib29","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2011.04.012","article-title":"The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease","volume":"33","author":"Kalinin","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib30","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1523\/JNEUROSCI.4668-14.2015","article-title":"Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease","volume":"35","author":"Kan","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","article-title":"Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model","volume":"33","author":"Kimura","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1471-4159.2009.06402.x","article-title":"Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9","volume":"111","author":"Koronyo-Hamaoui","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","article-title":"Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis","volume":"20","author":"Lambert","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib34","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nprot.2009.141","article-title":"Housing conditions and stimulus females: a robust social discrimination task for studying male rodent social recognition","volume":"4","author":"Macbeth","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jnr.20481","article-title":"Norepinephrine protects cortical neurons against microglial-induced cell death","volume":"81","author":"Madrigal","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1523\/JNEUROSCI.4926-08.2009","article-title":"Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline","volume":"29","author":"Madrigal","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuropharm.2015.08.032","article-title":"Noribogaine is a G-protein biased kappa-opioid receptor agonist","volume":"99","author":"Maillet","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-7-94","article-title":"beta-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices","volume":"7","author":"Markus","year":"2010","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib39","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: Essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","article-title":"Noradrenergic changes, aggressive behavior, and cognition in patients with dementia","volume":"51","author":"Matthews","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib42","doi-asserted-by":"crossref","first-page":"e103606","DOI":"10.1371\/journal.pone.0103606","article-title":"A\u00a0physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease","volume":"9","author":"Modi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuroscience.2011.02.049","article-title":"Norepinephrine and ss(1)-adrenergic signaling facilitate activation of hippocampal CA1 pyramidal neurons during contextual memory retrieval","volume":"181","author":"Murchison","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(04)00259-4","article-title":"A\u00a0distinct role for norepinephrine in memory retrieval","volume":"117","author":"Murchison","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.01.010_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-140036","article-title":"Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AbetaPPL\/S transgenic mice","volume":"42","author":"Nguyen","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib47","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nlm.2009.05.001","article-title":"Failures to reconsolidate memory in a mouse model of Alzheimer's disease","volume":"92","author":"Ohno","year":"2009","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib49","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/35094577","article-title":"Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors","volume":"2","author":"Pierce","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib51","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","article-title":"beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway","volume":"186","author":"Qian","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/156720511795256017","article-title":"How to get from here to there: macrophage recruitment in Alzheimer's disease","volume":"8","author":"Rezai-Zadeh","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JGP.0b013e318181276a","article-title":"Effects of cardiovascular medications on rate of functional decline in Alzheimer disease","volume":"16","author":"Rosenberg","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ynstr.2015.09.002","article-title":"Locus Coeruleus, norepinephrine and Abeta peptides in Alzheimer's disease","volume":"2","author":"Ross","year":"2015","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib56","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuint.2013.07.006","article-title":"Stimulation of central beta2-adrenoceptors suppresses NFkappaB activity in rat brain: a role for IkappaB","volume":"63","author":"Ryan","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/157015908785777229","article-title":"Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation","volume":"6","author":"Samuels","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib58","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.neurobiolaging.2013.05.003","article-title":"Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease","volume":"34","author":"Saul","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib59","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1523\/JNEUROSCI.4586-14.2015","article-title":"Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease","volume":"35","author":"Savage","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib60","doi-asserted-by":"crossref","first-page":"17501","DOI":"10.1073\/pnas.0607207103","article-title":"Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus","volume":"103","author":"Saxe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib61","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pbb.2014.11.006","article-title":"Effects of methylphenidate on the behavior of male 5xFAD mice","volume":"128","author":"Schneider","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib64","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.1523\/JNEUROSCI.2122-11.2011","article-title":"Stress and glucocorticoids impair memory retrieval via beta2-adrenergic, Gi\/o-coupled suppression of cAMP signaling","volume":"31","author":"Schutsky","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib65","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1101\/lm.2302811","article-title":"Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi\/o-coupled beta2-adrenergic signaling","volume":"18","author":"Schutsky","year":"2011","journal-title":"Learn Mem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrneurol.2010.71","article-title":"Systemic inflammatory cells fight off neurodegenerative disease","volume":"6","author":"Schwartz","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1471-4159.1987.tb05649.x","article-title":"Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia","volume":"48","author":"Shimohama","year":"1987","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2015.12.003","article-title":"Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer's Disease","volume":"291","author":"Sil","year":"2016","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fnins.2014.00315","article-title":"Inflammasomes in neuroinflammation and changes in brain function: a focused review","volume":"8","author":"Singhal","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0765.2005.00845.x","article-title":"Norepinephrine stimulates calprotectin expression in human monocytic cells","volume":"41","author":"Suryono","year":"2006","journal-title":"J.\u00a0Periodontal Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jnr.10399","article-title":"Existence of functional beta1- and beta2-adrenergic receptors on microglia","volume":"70","author":"Tanaka","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(93)91201-3","article-title":"Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease","volume":"631","author":"Tejani-Butt","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hipo.22394","article-title":"Neuromodulatory signaling in hippocampus-dependent memory retrieval","volume":"25","author":"Thomas","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.01.010_bib74","doi-asserted-by":"crossref","first-page":"414173","DOI":"10.1155\/2015\/414173","article-title":"Retrosplenial cortex and long-Term memory: molecules to behavior","volume":"2015","author":"Todd","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib75","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2012.05.008","article-title":"Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-beta peptide via action at beta-adrenoceptors and activation of cAMP\/PKA pathway in human THP-1 macrophages","volume":"236","author":"Yang","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.010_bib77","first-page":"193","article-title":"Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization","volume":"5","author":"Zhang","year":"1997","journal-title":"Recept. Channels"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:21:07Z","timestamp":1749885667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":77,"alternative-id":["S0028390817300102"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}